HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rossana Lazcano Selected Research

Sirolimus (Rapamycin)

1/2023Case report: Responses to the combination of gemcitabine with sirolimus in two patients with TSC-mutated sarcomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rossana Lazcano Research Topics

Disease

19Neoplasms (Cancer)
05/2024 - 01/2021
4Sarcoma (Soft Tissue Sarcoma)
05/2024 - 01/2023
3Neoplasm Metastasis (Metastasis)
01/2024 - 01/2021
2Melanoma (Melanoma, Malignant)
05/2024 - 01/2021
1Carcinogenesis
05/2024
1Small Cell Carcinoma
04/2024
1Leiomyosarcoma
04/2024
1Liposarcoma
02/2024
1Inflammation (Inflammations)
01/2024
1Lung Neoplasms (Lung Cancer)
01/2024
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2024
1Uterine Diseases (Endometrial Disease)
03/2023
1Perivascular Epithelioid Cell Neoplasms
01/2023
1Retinoblastoma (Glioblastoma, Retinal)
01/2023
1Hematologic Neoplasms (Hematological Malignancy)
01/2022
1Myxoid Liposarcoma
01/2022
1Osteosarcoma (Osteogenic Sarcoma)
01/2022
1Colorectal Neoplasms (Colorectal Cancer)
01/2021
1Neurofibrosarcoma (MPNST)
01/2021

Drug/Important Bio-Agent (IBA)

5Proteins (Proteins, Gene)FDA Link
05/2024 - 01/2021
4Immune Checkpoint InhibitorsIBA
05/2024 - 03/2023
4RNA (Ribonucleic Acid)IBA
11/2023 - 01/2021
4Biomarkers (Surrogate Marker)IBA
03/2023 - 01/2021
3ChromatinIBA
01/2022 - 01/2021
2NivolumabIBA
02/2024 - 01/2024
2IpilimumabIBA
02/2024 - 01/2024
2DNA (Deoxyribonucleic Acid)IBA
08/2023 - 01/2023
2Formaldehyde (Formol)FDA Link
01/2022 - 01/2021
2ParaffinIBA
01/2022 - 01/2021
1Ribonucleases (Ribonuclease)IBA
04/2024
1ONC212IBA
01/2024
1Therapeutic UsesIBA
01/2024
1TIC10 compoundIBA
01/2024
1GemcitabineFDA Link
01/2023
1MTOR InhibitorsIBA
01/2023
1Sirolimus (Rapamycin)FDA Link
01/2023
1abemaciclibIBA
01/2023
1A-Form DNA (A-DNA)IBA
01/2023
1AlbuminsIBA
01/2023
1AntigensIBA
01/2023
1trans-sodium crocetinate (crocetin)IBA
01/2023
1Adenosine Triphosphate (ATP)IBA
01/2022
1Surface Antigens (Surface Antigen)IBA
01/2022
1Matrix Metalloproteinase 14 (MT1-MMP)IBA
01/2022
1Immunoconjugates (Immunoconjugate)IBA
01/2022
1Oncogene Proteins (Oncogene Protein)IBA
01/2022
1Immunotoxins (Immunotoxin)IBA
01/2022
1Membrane Proteins (Integral Membrane Proteins)IBA
01/2022
1Adenosine (Adenocard)FDA LinkGeneric
01/2022
1Histones (Histone)IBA
01/2021
1Polycomb Repressive Complex 2IBA
01/2021
1Lysine (L-Lysine)FDA Link
01/2021
1durvalumabIBA
01/2021
1tremelimumabIBA
01/2021
1Transcription Factors (Transcription Factor)IBA
01/2021
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2021

Therapy/Procedure

7Immunotherapy
01/2024 - 01/2021
6Therapeutics
05/2024 - 01/2021
1Neoadjuvant Therapy
02/2024
1Radiotherapy
02/2024
1Drug Therapy (Chemotherapy)
01/2023